Transforming growth factor-β1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells

Blood

Volumn 90, Issue 9, 1997, Pages 3395-3403

  Dybedal, Ingunn ^b   Guan, Fengan ^b   Borge, Ole Johan ^b   Veiby, Ole Retter ^b   Ramsfjell, Veslemøy ^b   Nagata, Shigekazu ^b   Jacobsen, Sten Eirik W ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; FAS ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; GROWTH INHIBITION; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030788803     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3395     Document Type: Article

References (43)

1. Metcalf D; Hematopfietic regulators; Redundancy or subtlety? Blood 82:3515, 1993
2. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
3. Sachs L, Lotem J: Control of programmed cell death in normal and leukemic cells: New implications for therapy. Blood 82; 15, 1993
4. Broxmeyer HE; Biomolecule-cell interactions and the regulation of myelopoiesis; An update, in Murphy MJ (ed): Concise Reviews in Clinical and Experimental Hematology. Dayton, OH, AlphaMed, 1993, p 119
5. 1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 80:1750, 1992
6. Jacobsen FW, Stokke T, Jacobsen SEW: Transforming growth factor-β potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells. Blood 86:2957, 1995
7. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
8. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
9. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148:1274, 1992
10. Smith CA, Farrah T, Goodwin RG: The TNF receptor super-family of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959, 1994
11. Nagata S, Golstein P: The Fas death factor. Science 267:1449, 1995
12. Nagata S, Suda T: Fas and Fas ligand: Ipr and gld mutations. Immunol Today 1:39, 1995
13. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NA, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969, 1994
14. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IAG, Debatin KM, Fischer A, de Villartay JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347, 1995
15. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY, Strober W, Lenardo MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935, 1995
16. Kobayashi N, Hamamoto Y,Yamamoto N, Ishii A, Yonehara M, Yonahara S: Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci USA 87:9620, 1990
17. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitarnura Y, Itoh N, Suda T, Nagata S: Lethal effect of the anti-Fas antibody in mice. Nature 364:806, 1993
18. Galle PR, Hofmann JW,Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, Runkell L: Involvement of the CD95 (APO-I/Fas) receptor and ligand in liver damage. J Exp Med 182:1223, 1995
19. Trauth BC, Klas C, Peters AMJ, Matzku S, Møller P, Falk W, Debatin K-M, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301, 1989
20. Iwai K, Miyawaki T, Takizawa T, Konno A , Ohta K, Yachie A, Seki H, Taniguchi N: Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201, 1994
21. + cells of patients with aplastic anaemia. Br J Haematol 91:245, 1995
22. + human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183, 1995
23. Nagafuji K, Shibuya T, Harada M, Mizuno S-I, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y: Functional expression of Fas antigen (CD95) of hematopoietic progenitor cells. Blood 86:883, 1995
24. 1 on normal and neoplastic haemopoiesis, in Clinical Applications of TGF-β. Ciba Found Symp 157:212, 1997
25. Keller JR, Jacobsen SEW, Sill KT, Ellingsworth LR, Ruscetti FW: Stimulation of granulopoiesis by transforming growth factor β: Synergy with granulocyte/macrophage-colony-stimulating factor. Proc Natl Acad Sci USA 88:7190, 1991
26. 1or Rb oligonucleotides. J Exp Med 174:925, 1991
27. Ohish K, Katayuma N, Itoh R, Mahmud N, Miwa H, Kita K, Minami N, Shirakawa S, Lyman SD, Shiku H: Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-β. Blood 87:1718, 1996
28. 1 gene results in multifocal inflammatory disease. Nature 359:693, 1992
29. 1null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770, 1993
30. Roberts AB, Sporn MB: The transforming growth factor-βs, in Sporn MB, Roberts AB (eds): Handbook of Experimental Pharmacology, vol 95/1, Peptide Growth Factors and Their Receptors 1. New York, NY, Springer-Verlag, 1990, p 419
31. Massagué J: The transforming growth factor-β family. Annu Rev Biol 6:597, 1990
32. + thymocytes by the anti-Fas antibody. J Exp Med 181:485, 1995
33. Spangrude GJ, Heimfeld S, Weissman IL: Purification and characterization of mouse hematopoietic stem cells. Science 241:58, 1988
34. Spangrude GJ, Scollay R: A simplified method for enrichment of mouse hematopoietic stem cells. Exp Hematol 18:920, 1990
35. Jacobsen SEW, Okkenhaug C, Myklebust J, Veiby OP, Lyman SD: The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells: Synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J Exp Med 181:1357, 1995
36. Metcalf D: The Hemopoietic Colony Stimulating Factors. Amsterdam, The Netherlands, Elsevier, 1984
37. Gorczyca W, Gong J, Darzynkiewicz Z: Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53:1945, 1993
38. Jacobsen SEW, Ruscetti FW, Dubois CM, Keller JR: Tumor necrosis factor a directly and indirectly regulates hematopoietic progenitor cell proliferation: Role of colony-stimulating factor receptor modulation. J Exp Med 175:1759, 1992
39. Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppen-heim JJ, Keller JR: Transforming growth factor β is a potent inhibitor of interleukin 1 (IL-1) receptor expression: Proposed mechanism of inhibition of IL-1 action. J Exp Med 172:737, 1990
40. Jacobsen SEW, Ruscetti FW, Dubois CM, Lee J, Boone TC, Keller JR: Transforming growth factor-β trans-modulates the expression of colony stimulating factors on murine hematopoietic progenitor cell lines. Blood 77:1706, 1991
41. Dubois CM, Ruscetti FW, Stankova J, Keller JR: Transforming growth factor-β regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. Blood 83:3138, 1994
42. 1. J Immunol 156:459, 1996
43. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A: Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. J Clin Invest 94:954, 1994